(−)-Nyasol, isolated from Anemarrhena asphodeloides suppresses neuroinflammatory response through the inhibition of I-κBα degradation in LPS-stimulated BV-2 microglial cells

References

• González-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999;22:219–240.
   PubMed Web of Science ®Google Scholar
• Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Peterson PK. Role of microglia in central nervous system infections. Clin Microbiol Rev 2004;17:942–64.
   PubMed Web of Science ®Google Scholar
• Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005;76:77–98.
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Yamauchi T. Saponins of timo (Anemarrhenae rhizoma). II. Structure of timosaponin A-III. Chem Pharm Bull 1963;11:1221–1224.
   PubMedGoogle Scholar
• Zhou T, Zhu Z, Wang C, Fan G, Peng J, Chai Y et al. On-line purity monitoring in high-speed counter-current chromatography: application of HSCCC-HPLC-DAD for the preparation of 5-HMF, neomangiferin and mangiferin from Anemarrhena asphodeloides Bunge. J Pharm Biomed Anal 2007;44:96–100.
   PubMed Web of Science ®Google Scholar
• Saito S, Nagase S, Ichinose K. New steroidal saponins from the rhizomes of Anemarrhena asphodeloides Bunge (Liliaceae). Chem Pharm Bull 1994;42:2342–2345.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Ryu JH. Hinokiresinol: a novel inhibitor of LTB4 binding to the human neutrophils. Planta Med 1999;65:391.
   PubMed Web of Science ®Google Scholar
• Jeong SJ, Higuchi R, Ono M, Kuwano M, Kim YC, Miyamoto T. cis-Hinokiresinol a norlignan from Anemarrhena asphodeloides, inhibits angiogenic response in vitro and in vivo. Biol Pharm Bull 2003;26:1721–1724.
   PubMed Web of Science ®Google Scholar
• Lim H, Nam JW, Seo EK, Kim YS, Kim HP. (-)-Nyasol (cis-hinokiresinol), a norneolignan from the rhizomes of Anemarrhena asphodeloides, is a broad spectrum inhibitor of eicosanoid and nitric oxide production. Arch Pharm Res 2009;32:1509–1514.
   PubMed Web of Science ®Google Scholar
• Bae G, Yu JR, Lee J, Chang J, Seo EK. Identification of nyasol and structurally related compounds as the active principles from Anemarrhena asphodeloides against respiratory syncytial virus (RSV). Chem Biodivers 2007;4:2231–2235.
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131–138.
   PubMed Web of Science ®Google Scholar
• Wen W, Sanelli T, Ge W, Strong W, Strong MJ. Activated microglial supernatant induced motor neuron cytotoxicity is associated with upregulation of the TNFR1 receptor. Neurosci Res 2006;55:87–95.
   PubMed Web of Science ®Google Scholar
• Rothwell N, Allan S, Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 1997;100:2648–2652.
   PubMed Web of Science ®Google Scholar
• Hill KE, Zollinger LV, Watt HE, Carlson NG, Rose JW. Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage. J Neuroimmunol 2004;151:171–179.
   PubMed Web of Science ®Google Scholar
• Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 2006;12:225–229.
   PubMed Web of Science ®Google Scholar
• Hoozemans JJM, Rozemuller AJM, Janssen I, De Groot CJA, Veerhuis R, Eikelenboom P. Cyclooxygenase expression in microglia and neurons in Alzheimer’s disease and control brain. Acta Neurophathol 2001;101:2–8.
   PubMed Web of Science ®Google Scholar
• García-Bueno B, Serrats J, Sawchenko PE. Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. J Neurosci 2009;29:12970–12981.
   PubMed Web of Science ®Google Scholar
• Wang H, Hitron IM, Iadecola C, Pickel VM. Synaptic and vascular associations of neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex. Cereb Cortex 2005;15:1250–1260.
   PubMed Web of Science ®Google Scholar
• Choi SH, Langenbach R, Bosetti F. Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J 2008;22:1491–1501.
   PubMed Web of Science ®Google Scholar
• Choi SH, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 2009;30:174–181.
   PubMed Web of Science ®Google Scholar
• Calvello R, Panaro MA, Carbone ML, Cianciulli A, Perrone MG, Vitale P, Malerba P, Scilimati A. Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells. Pharmacol Res 2012;65:137–148.
   PubMed Web of Science ®Google Scholar
• Li P, Lu J, Kaur C, Sivakumar V, Tan KL, Ling EA. Expression of cyclooxygenase-1/-2, microsomal prostaglandin-E synthase-1 and E-prostanoid receptor 2 and regulation of inflammatory mediators by PGE2 in the amoeboid microglia in hypoxic postnatal rats and murine BV-2 cells. Neuroscience 2009;164:948–962.
   PubMed Web of Science ®Google Scholar
• Font-Nieves M, Sans-Fons MG, Gorina R, Bonfill-Teixidor E, Salas-Pérdomo A, Marquez-Kisinousky L, Santalucia T, Planas AM. Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes. J Biol Chem 2012;287:6454–6468.
   PubMed Web of Science ®Google Scholar
• Kim IS, Ko HM, Koppula S, Kim BW, Choi DK. Protective effect of Chrysanthemum indicum Linne against 1-methyl-4-phenylpridinium ion and lipopolysaccharide-induced cytotoxicity in cellular model of Parkinson’s disease. Food Chem Toxicol 2011;49:963–973.
   PubMed Web of Science ®Google Scholar
• Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κ B activity. Annu Rev Immunol 2000;18:621–663.
   PubMed Web of Science ®Google Scholar
• Camandola S, Mattson MP. NF-kappa B as a therapeutic target in neurodegenerative diseases. Expert Opin Ther Targets 2007;11:123–132.
   PubMed Web of Science ®Google Scholar
• Koistinaho M, Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 2002;40:175–183.
   PubMed Web of Science ®Google Scholar
• Ock J, Kim S, Yi KY, Kim NJ, Han HS, Cho JY, Suk K. A novel anti-neuroinflammatory pyridylimidazole compound KR-31360. Biochem Pharmacol 2010;79:596–609.
   PubMed Web of Science ®Google Scholar
• Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001;480–481:243–268.
   PubMed Web of Science ®Google Scholar
• Lin MW, Tsao LT, Chang LC, Chen YL, Huang LJ, Kuo SC, Tzeng CC, Lee MR, Wang JP. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway. Biochem Pharmacol 2007;73:1796–1806.
   PubMed Web of Science ®Google Scholar
• Chao CL, Weng CS, Chang NC, Lin JS, Kao ST, Ho FM. Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia. Nutr Res 2010;30:858–864.
   PubMed Web of Science ®Google Scholar